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Improved stability of live attenuated vaccine gdhA derivative Pasteurella multocidaB:2 
by freeze drying method for use as animal vaccine 
 ABSTRACT 
The efficacy of attenuated strain of gdhA derivative Pasteurella multocidaB:2 mutant as 
a live vaccine to control haemorrhagic septicaemia (HS) disease in cattle and buffaloes has 
been demonstrated. In order to use P. multocida B:2 mutant as a commercial product, it is 
essential to optimise its formulation for high viability and stability of the live cells. The 
effectiveness of freeze-drying process using different protective agentformulations for 
improving cells viability was explored. Sugar and nitrogen compounds were used as 
protective agents in freeze-drying and the capability of these compounds in maintaining the 
viability of mutant P. multocida B:2 during subsequent storage was investigated. A complete 
loss in viability of freeze-dried mutant P. multocida B:2 was monthly observed until 6–12 
months of storage at −30 °C, 4 °C and 27 °C when nitrogen compound or no protective agent 
was added. Trehalose and sucrose showed significantly high survival rate of 93–95% 
immediately after freeze-drying and the viability was retained during the subsequent storage 
at −30 °C and 4 °C. A smooth cell surface without any cell-wall damage was observed for the 
cells formulated with trehalose under scanning electron micrograph. This study presented a 
freeze-drying process generating a dried live attenuated vaccine formulation with high 
stability for commercial applications. 
Keyword: gdhA derivative Pasteurella multocida B:2 mutant; Protective agents; Freeze 
drying; Cell viability; Storage; Cell morphology 
 
